SCHEMBL3052747

SCHEMBL3052747

CCOC(=O)C1CCC=CCCCCN(C)C(=O)C2CC(Oc3cc(-c4csc(NC(C)C)n4)nc4cc(OC)ccc34)CC2C(=O)N1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 2/20 0.48
▸ CTSS P25774 1/20 0.43
▸ ADRB3 P13945 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ SLC5A7 Q9GZV3 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ IGF1R P08069 1/20 0.30
▸ MET P08581 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ PPP3CB P16298 1/20 0.30
▸ ACACB O00763 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3046054 0.93 CTSB (0.52) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL3039920 0.86 CTSB (0.61) CTSBCTSSKCNH2HRH3NPC1
SCHEMBL3052749 0.85 CTSB (0.61) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL13248870 0.85 CTSB (0.61) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL3052744 0.85 CTSB (0.61) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL3046050 0.81 CTSB (0.65) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL12018629 0.81 CTSB (0.65) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL3046058 0.81 CTSB (0.65) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL3045946 0.81 CTSB (0.63) CTSBCTSSADRB3ADRA2BADRA2C
SCHEMBL12018606 0.79 CTSB (0.79) CTSBCTSSADRB3ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7671032-B2 HCV NS-3 serine protease inhibitors MEDIVIR AB (SE) 2010-03-02 — — US claimed
US-7671032-B2 HCV NS-3 serine protease inhibitors MEDIVIR AB (SE) 2010-03-02 — — US disclosed
Send feedback